Vishay Precision Grp. (VPG): Anyone know anything about Wes Cummins,...

Anyone know anything about Wes Cummins, the director

InvestorDavid · 2022-12-16T16:06:47.9530000Z

Anyone know anything about Wes Cummins, the director whose been doing the insider buying?

Play Episode

7min

Proactive - Interviews for investors

Chariot CFO on $175M financing and 75MW solar project

Chariot Ltd (AIM:CHAR, OTC:OIGLF) chief financial officer Julian Maurice-Williams takes Proactive's Stephen Gunnion through two major announcements from the company's renewable division. The first announcement covers the financing closure of Etana Energy, Chariot’s electricity trading joint venture in South Africa. The financing totals $175 million, with backing from institutions like Norfund and Standard Bank, Africa's biggest bank. Maurice-Williams explained, “Etana is fully funded, and this strengthens its balance sheet, making it bankable and creditworthy.” The second update is a power purchase agreement for a 75-megawatt solar project in South Africa, with electricity to be traded through Etana. This project, set for construction in Q2, was enabled by the guarantee financing secured by Chariot. Maurice-Williams emphasised that these developments mark “two big steps forward for our renewable division towards first revenues.” Chariot expects further renewable projects to reach financial close soon, expanding both its trading and generation revenue streams. The company also continues advancing its oil and gas projects in Morocco and other African markets, with updates expected in the near future. For more updates from Chariot Ltd and other companies, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #ChariotLtd #RenewableEnergy #EtanaEnergy #SolarPower #EnergyInvestment #SouthAfricaEnergy #CleanEnergy #FinancialNews #Investing #ProactiveInvestors

Proactive - Interviews for investors

Mag Mile Capital accelerates growth with $80M in deals, AI-Powered expansion strategy

Mag Mile Captial CEO Rushi Shah joined Steve Darling from Proactive to discuss the company’s rapid expansion in 2024, highlighted by over $80 million in commercial real estate transactions in just the past two months and an active pipeline of $250 million. Recent closings include a $14.5 million deal in Rochester, New York, and a $13 million transaction in Harker Heights, Texas. Shah emphasized Mag Mile’s transformation into a tech-driven finance company, integrating AI and machine learning to streamline underwriting and deal execution. The firm’s proprietary Cap Logic platform is designed to reduce transaction cycle times by up to 50 times, significantly improving efficiency. Looking ahead, Shah outlined his vision to scale Mag Mile into a $1 billion company through strategic acquisitions and a roll-up strategy, consolidating service providers under the firm’s expanding umbrella. “We are aggressively employing a roll-up strategy,” he noted, reinforcing the company’s commitment to growth. With ample capital, strong demand for real estate financing, and advanced technology integration, Mag Mile Capital is well-positioned to capitalize on industry trends and redefine commercial real estate finance. #proactiveinvestors #magmilecapitalinc #otcqb #mmcp #capital #RealEstateFinance #AIinFinance #CommercialLoans #CRE #Investment #RealEstateInvesting #ProactiveInvestors #CapLogic #Fintech

Proactive - Interviews for investors

Imugene’s Azercell shows strong response in blood cancer

Imugene Ltd CEO Leslie Chong talked with Kerry Stevenson at Proactive about the FDA's fast-track designation for its immunotherapy candidate, Azercell. The therapy, an allogeneic off-the-shelf CAR-T treatment, has shown promising results in patients with diffuse large B-cell lymphoma (DLBCL), a highly aggressive form of blood cancer. Chong highlighted that four out of seven patients treated with Azercell achieved complete response, meaning their cancer was no longer detectable. The longest response duration has now exceeded 11 months. “The FDA has recognised the importance of a product like this and has given us fast-track designation,” Chong stated. The FDA's fast-track status allows Imugene to expedite regulatory discussions and move towards potential commercialization more efficiently. The company sees this as a critical milestone, with Chong emphasising that the priority now is gathering sufficient data to advance towards registration studies. With an estimated 80,000 new DLBCL cases diagnosed annually in the US, Azercell could address a significant unmet need, especially for patients who have exhausted other treatment options. For more updates on Imugene and other biotech innovations, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and enable notifications for future content. #Imugene #Biotech #CancerResearch #FDA #CAR_T #Oncology #BloodCancer #DLBCL #MedicalBreakthrough #FastTrack #Immunotherapy

Proactive - Interviews for investors

GinsGlobal Tech Megatrend ETF: diversified, AI-driven, and delivering strong returns

Anthony Ginsberg, CEO of GinsGlobal Index Fund, recently spoke with Steve Darling from Proactive to discuss the structure, performance, and strategic advantages of the GinsGlobal Tech Megatrend ETF. He highlighted three core strengths of the fund: its equally weighted structure, international diversification, and targeted exposure to high-growth technology sectors such as AI, robotics, cloud computing, and cybersecurity. Unlike traditional Nasdaq-style funds that are often dominated by a few large-cap stocks, the Tech Megatrend ETF avoids over-concentration, with its largest holdings representing only about 9% of the total portfolio weight. The fund also offers broad international exposure, with 60% of holdings based in the U.S., 10% in China, and approximately 20% across broader Asia. This balanced approach extends across eight key subthemes, including digital entertainment, gene therapy, and social media. The ETF has delivered a 17% return over the past year, with strong performance from companies such as BYD and Alibaba. Ginsberg noted that major mergers and acquisitions in the tech sector, including Microsoft’s $72 billion Activision deal and Google Cloud’s expansion into cybersecurity, are further driving momentum. He also pointed to reshoring trends that are benefiting automation and AI-driven businesses, positioning the fund to capitalize on these market shifts. In terms of valuation, Ginsberg emphasized that the ETF maintains an average price-to-earnings ratio of 18 to 19 times future earnings, which he considers reasonable compared to historical tech market bubbles. Ginsberg concluded by highlighting the increasing role of AI in digital entertainment and the ongoing convergence of major tech trends within the ETF’s portfolio. With its diversified, forward-looking investment strategy, the GinsGlobal Tech Megatrend ETF continues to present a compelling opportunity for investors seeking exposure to the next wave of technological innovation. #TechMegatrendETF,

Followers	0
Posts	20
Boards Moderated	0
Alias Born	05/10/2017

Volume:	109,658
Day Range:	23.76 - 24.8812
Bid:
Ask:
Last Trade Time:	7:00:00 PM EDT
Total Trades:	2,667

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

VPG Detailed Quote

Recent VPG News

More VPG News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent VPG News

Go Ad-Free